Literature DB >> 1285652

Peptides and cytokines.

J M Schröder1.   

Abstract

In the last decade a number of proteinaceous inflammatory mediators have been structurally characterized. Two of these mediators, tumor necrosis factor alpha (TNF alpha) and Interleukin 1 alpha and beta (IL-1), have pleiotropic properties. Both cytokines are now known to be potent inducers of a number of cell-selective chemotactic cytokines, which belong to a novel superfamily of structurally related low-molecular-weight proteins. One of the most prominent members is termed "IL-8" and represents a neutrophil-selective attractant, whereas another one called "monocyte chemotactic protein 1 (MCP-1)" is a monocyte-selective chemotaxin. Other members seem to be selective chemotaxins for other leukocyte types and subsets. These chemotactic cytokines are produced by a variety of different cells under appropriate stimulation conditions. Large amounts of IL-8 have been detected in scales of psoriatic lesions and may be of importance in explaining predominant neutrophil infiltration in psoriatic lesions. Regulation of gene expression and/or release of these chemotactic cytokines may occur by IL-1 receptor antagonists or soluble TNF-alpha-receptors. So far, natural antagonists to these chemotactic cytokines have not been described; however, pharmacological inhibition of its gene expression and/or release is possible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285652     DOI: 10.1007/bf00638236

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  31 in total

1.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production.

Authors:  C G Larsen; M Kristensen; K Paludan; B Deleuran; M K Thomsen; C Zachariae; K Kragballe; K Matsushima; K Thestrup-Pedersen
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

3.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

Review 4.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils.

Authors:  K Georgilis; C Schaefer; C A Dinarello; M S Klempner
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

6.  Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.

Authors:  R Gillitzer; R Berger; V Mielke; C Müller; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1991-07       Impact factor: 8.551

7.  Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts.

Authors:  A Tobler; R Meier; M Seitz; B Dewald; M Baggiolini; M F Fey
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

8.  Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.

Authors:  K Matsushima; C G Larsen; G C DuBois; J J Oppenheim
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.

Authors:  J M Schröder; N L Persoon; E Christophers
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.

Authors:  A Walz; B Dewald; V von Tscharner; M Baggiolini
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  2 in total

1.  The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes.

Authors:  T Yamamoto; T Nakane; T Osaki
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 2.  New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.

Authors:  Isabel Corraliza-Gorjón; Beatriz Somovilla-Crespo; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.